IFIT3调解TBK1酸化以促进pDCs的激活,并加剧小鼠的全身性硬化症

相关实验视频

Updated: Jun 12, 2025

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

Xiangyang Huang¹, Yi Liu², Xia Rong¹

¹Department of Rheumatology and Immunology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.

Clinical and translational medicine

|September 21, 2024

概括

IFIT3/TBK1通路激活血类树突细胞 (pDC),导致系统性硬化症 (SSc). 针对这种途径在SSc模型中显示有望减少纤维化.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
类风湿病学类风湿病学

背景情况:

系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,以纤维化为特征.
等离子体树突细胞 (pDCs) 参与了SSc.的病变发生.
在SSc中驱动pDC激活的精确分子机制尚不完全理解.

研究的目的:

研究IFIT3/TBK1信号通路在pDC激活中的作用.
确定这条路径对SSc发展的影响.
评估针对SSc.中的IFIT3/TBK1的治疗潜力.

主要方法:

单细胞和转录组RNA测序以分析pDCs和IFIT3表达在SSc.
在体外实验中评估IFIT3/TBK1通路干预对pDC和纤维细胞的影响.
使用CRISPR/Cas9进行纤维化研究的IFIT3淘汰赛小鼠模型 (IFIT3-/-) 的生成.

主要成果:

IFIT3作为TBK1的上游调节器,对pDC激活至关重要.
对IFIT3/TBK1通路的干预抑制了pDC细胞因子的释放,并改变了纤维细胞的功能.
IFIT3-/-小鼠模型显示皮肤和肺纤维化减少,这表明治疗效益.

结论:

IFIT3/TBK1信号通路是SSc中pDC激活的一个关键驱动器.
针对这种途径为SSc提供了潜在的治疗策略.
这项研究确定IFIT3是SSc病变发生的关键基因.

关键词:

这就是CRISPR/Cas9的作用.IFIT3/TBK1信号通道的信号通道纤维化纤维化 pDCs的激活方式在 scRNA-seqq 中.系统性硬化症系统性硬化症

更多相关视频

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...